Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Human Hypertension|June 3, 2011
Geographic variation in left ventricular mass and mass index: a systematic reviewK K Poppe, M Edgerton Bachmann, C M Triggs, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2011
Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactionsBolin Liu, Zeying Fan, Susan M Edgerton, et al.
Cancer Research|August 5, 2008
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosisAnjali Naresh, Ann D Thor, Susan M Edgerton, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathwaysM Edgerton, S E Koshlukova, M W Araujo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancersS Krajewski, A D Thor, S M Edgerton, et al.
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancerReema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
Oncotarget|December 2, 2015
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cellsHui Lyu, Xiao He Yang, Susan M Edgerton, et al.
Molecular Cancer Research : MCR|October 29, 2009
Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signalingBolin Liu, Dalia Ordonez-Ercan, Zeying Fan, et al.
The Journal of Biological Chemistry|August 1, 1998
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicansM Edgerton, S E Koshlukova, T E Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patientsMichael P DiGiovanna, David F Stern, Susan M Edgerton, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Human Hypertension|June 3, 2011
Geographic variation in left ventricular mass and mass index: a systematic reviewK K Poppe, M Edgerton Bachmann, C M Triggs, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2011
Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactionsBolin Liu, Zeying Fan, Susan M Edgerton, et al.
Cancer Research|August 5, 2008
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosisAnjali Naresh, Ann D Thor, Susan M Edgerton, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathwaysM Edgerton, S E Koshlukova, M W Araujo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancersS Krajewski, A D Thor, S M Edgerton, et al.
Cell Cycle (Georgetown, Tex.)|February 27, 2016
Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancerReema Wahdan-Alaswad, J Chuck Harrell, Zeying Fan, et al.
Oncotarget|December 2, 2015
The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cellsHui Lyu, Xiao He Yang, Susan M Edgerton, et al.
Molecular Cancer Research : MCR|October 29, 2009
Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signalingBolin Liu, Dalia Ordonez-Ercan, Zeying Fan, et al.
The Journal of Biological Chemistry|August 1, 1998
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicansM Edgerton, S E Koshlukova, T E Lo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patientsMichael P DiGiovanna, David F Stern, Susan M Edgerton, et al.
Pageof 9